Literature DB >> 19411630

Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex.

Gabriela M Baerlocher1, Alicia Rovó, Astrid Müller, Sybille Matthey, Martin Stern, Jörg Halter, Dominik Heim, Johannes Rischewski, Alois Gratwohl, André Tichelli.   

Abstract

In this single-center, cross-sectional study, we evaluated 44 very long-term survivors with a median follow-up of 17.5 years (range, 11-26 years) after hematopoietic stem cell transplantation. We assessed the telomere length difference in human leukocyte antigen-identical donor and recipient sibling pairs and searched for its relationship with clinical factors. The telomere length (in kb, mean +/- SD) was significantly shorter in all recipient blood cells compared with their donors' blood cells (P < .01): granulocytes (6.5 +/- 0.9 vs 7.1 +/- 0.9), naive/memory T cells (5.7 +/- 1.2 vs 6.6 +/- 1.2; 5.2 +/- 1.0 vs 5.7 +/- 0.9), B cells (7.1 +/- 1.1 vs 7.8 +/- 1.1), and natural killer/natural killer T cells (4.8 +/- 1.0 vs 5.6 +/- 1.3). Chronic graft-versus-host disease (P < .04) and a female donor (P < .04) were associated with a greater difference in telomere length between donor and recipient. Critically short telomeres have been described in degenerative diseases and secondary malignancies. If this hypothesis can be confirmed, identification of recipients at risk for cellular senescence could become part of monitoring long-term survivors after hematopoietic stem cell transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19411630     DOI: 10.1182/blood-2009-03-209833

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Authors:  Shahinaz M Gadalla; Tao Wang; Michael Haagenson; Stephen R Spellman; Stephanie J Lee; Kirsten M Williams; Jason Y Wong; Immaculata De Vivo; Sharon A Savage
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

2.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 3.  Telomeres, atherosclerosis, and the hemothelium: the longer view.

Authors:  Abraham Aviv; Daniel Levy
Journal:  Annu Rev Med       Date:  2011-10-17       Impact factor: 13.739

4.  Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Authors:  Régis Peffault de Latour; Rodrigo T Calado; Marc Busson; Jeffrey Abrams; Nadir Adoui; Marie Robin; Jérôme Larghero; Nathalie Dhedin; Alienor Xhaard; Emmanuel Clave; Dominique Charron; Antoine Toubert; Pascale Loiseau; Gérard Socié; Neal S Young
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

5.  Stem cells: Sex specificity in the blood.

Authors:  Dena S Leeman; Anne Brunet
Journal:  Nature       Date:  2014-01-23       Impact factor: 49.962

Review 6.  Telomere biology in hematopoiesis and stem cell transplantation.

Authors:  Shahinaz M Gadalla; Sharon A Savage
Journal:  Blood Rev       Date:  2011-07-20       Impact factor: 8.250

7.  Predicting clonal self-renewal and extinction of hematopoietic stem cells.

Authors:  Hans B Sieburg; Betsy D Rezner; Christa E Muller-Sieburg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

8.  Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Authors:  Shahinaz M Gadalla; Tao Wang; Casey Dagnall; Michael Haagenson; Stephen R Spellman; Belynda Hicks; Kristine Jones; Hormuzd A Katki; Stephanie J Lee; Sharon A Savage
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-15       Impact factor: 5.742

9.  Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.

Authors:  Yutaka Kawano; Haesook T Kim; Ken-Ichi Matsuoka; Gregory Bascug; Sean McDonough; Vincent T Ho; Corey Cutler; John Koreth; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2011-09-07       Impact factor: 22.113

10.  Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.

Authors:  Alicia Rovó; Thomas Daikeler; Jörg Halter; Dominik Heim; Dimitrios A Tsakiris; Martin Stern; Tuomas Waltimo; Jan Dirk Studt; Alan Tyndall; Alois Gratwohl; André Tichelli
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.